Wanting to know if any organizations have transitioned all their controlled substance infusions to the Alaris PCA Syringe Module for the purposes of securing controlled substances.
Interesting in knowing the formulary of medications that you have moved to that platform, any barriers to the change and other lessons learned that you would be able to share.
Thanks!
Lee

Lee M King
Medication Safety Officer
Sparrow Health System
517-364-5564
lee.king@sparrow.org

Does anyone have guidelines on concentration of potassium PHOSPHATE IV infusions to be given peripherally?

At my institution, for potassium CHLORIDE, we use a concentration of 10 mEq/100 mL (0.1 mEq/mL) for peripheral administration and up to 20 mEq/100 mL (0.2 mEq/mL) for central lines.

Our EHR (Epic) is set up to default all potassium PHOSPHATE doses to be diluted in 250 mL NS to infuse over 6 hours.

My hospital recently converted infusion pumps to the B Braun Infusomat Large Volume Pump. We are having some workflow issues in our critical care units. I would like to connect with anyone who currently uses these pumps in a critical care area to ask a few workflow questions. Please email me at kristen.r.rachinski@kp.org
Thank you!
Kristen

Colleagues:

As a courtesy to Eli Lilly and Company, as directed by the FDA, ISMP is emailing you to notify you of a bamlanivimab Dear HCP letter containing the following message:

"Refer only to the FDA Authorized Fact Sheet for bamlanivimab for preparation and administration instructions and disregard a document entitled “Bamlanivimab Alternative Preparation and Administration Information.”

Please see the attached letter to review the Dear HCP letter.

Mike

Hello All,
We are currently building the batched product formulary for our IV workflow software (BD IV Prep) at the system level. At this point, our health system consists of one academic medical center with several community hospitals.

Dear all,

My hospital is exploring the adaptation of Alaris-EPIC interoperability. I was told they previously explored this project three years ago and were told that Alaris interoperability does not support PCA and high risk infusions like heparin.

Is this true? it seems odd and counterintuitive if true.

Thank you all in advance for your help.

Sincerely,
Mohamed

Hello everyone,

Nitroglycerin for infusion is known to adsorb into PVC tubing. To what extent is variable and changes over time with the infusion.

I'm curious to learn more about how sites are approaching tubing with nitroglycerin:

1. For sites using a specialized low sorbing tubing set, what are safeguards implemented to promote consistent use of the specialized tubing for nitroglycerin including initial tubing sets and for tubing changes?

E.g., Creating a kit with tubing attached to nitroglycerin product.

Can anyone share their policy on how you monitor/regulate patients on a continuous infusion of a controlled substance that is being transported to another hospital outside of your institution?

Thank you,

Randi

There is also a discussion on ASHP message board regarding this topic, but I also wanted to check with the experts on this forum.

Does anyone have experience using Baxter's Mini-Bag Plus system for reconstituting 100mg powder vials and then administering a 100mg dose of Remdesivir?

My facility is having difficulty getting Glucagon ekits. However, we have vials of GlucaGen. Can these be used for a do-it-yourself ekit as this product is labeled for diagnostic use only. Also can anyone shed light on why it has that indication only? Also if it can be used for ekits,  what diluent should be used and how much of it, what size syringe and what gauge needle? Thanks for your help.